TrialThe Journal of clinical endocrinology and metabolism2022

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?

Priyadarshini Balasubramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.